C12N 2740/16111
Concerning hiv env
Official title: concerning HIV env
C12N2740/16111 (Concerning hiv env) appears on 1,582 US grants and 1,695 published applications in this corpus.
Search patents in C12N- Granted patents
- 1,582
- Published applications
- 1,695
- Assignees
- 832
- Inventors
- 3,038
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 9 | 0 |
| 1989 | 4 | 0 |
| 1990 | 5 | 0 |
| 1991 | 10 | 0 |
| 1992 | 18 | 0 |
| 1993 | 14 | 0 |
| 1994 | 21 | 0 |
| 1995 | 11 | 0 |
| 1996 | 44 | 0 |
| 1997 | 45 | 0 |
| 1998 | 110 | 0 |
| 1999 | 84 | 0 |
| 2000 | 76 | 0 |
| 2001 | 69 | 12 |
| 2002 | 53 | 63 |
| 2003 | 64 | 132 |
| 2004 | 39 | 105 |
| 2005 | 41 | 103 |
| 2006 | 44 | 99 |
| 2007 | 39 | 74 |
| 2008 | 44 | 71 |
| 2009 | 49 | 93 |
| 2010 | 48 | 77 |
| 2011 | 51 | 80 |
| 2012 | 47 | 92 |
| 2013 | 30 | 41 |
| 2014 | 45 | 57 |
| 2015 | 44 | 62 |
| 2016 | 38 | 73 |
| 2017 | 50 | 47 |
| 2018 | 59 | 47 |
| 2019 | 49 | 62 |
| 2020 | 46 | 56 |
| 2021 | 46 | 61 |
| 2022 | 34 | 41 |
| 2023 | 26 | 36 |
| 2024 | 34 | 42 |
| 2025 | 21 | 36 |
| 2026 | 20 | 33 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Rapid elicitation of broadly neutralizing bovine antibodies to HIV Env25 Aug 2026US 12,715,907 B2International AIDS Vaccine Initiative
- Methods and compositions for inducing an immune response using conserved element constructs18 Aug 2026US 12,709,635 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- HIV immunotherapy with no pre-immunization step18 Aug 2026US 12,709,753 B2American Gene Technologies International Inc.
- Modified envelope protein of human immunodeficiency virus and use thereof4 Aug 2026US 12,697,383 B2Xiamen Innovax Biotech Co., Ltd.
- Recombinant HIV Env polypeptides and their uses14 Jul 2026US 12,679,869 B2International AIDS Vaccine Initiative
- Improved alum-anchored immunogens1 Oct 2026US 2026/0295039 A1Massachusetts Institute of Technology
- Compositions comprising mrnas encoding hiv-1 membrane proximal external region (mper) peptides24 Sep 2026US 2026/0285910 A1
- Methods of producing hiv-1 envelope glycoproteins and guanosine microparticles thereof24 Sep 2026US 2026/0285913 A1
- Immunogenic trimers17 Sep 2026US 2026/0273042 A1International AIDS Vaccine Initiative
- Dual-germline antibody engager hiv-1 envelope chimeric immunogens27 Aug 2026US 2026/0248907 A1The United States of America, as represented by the Secretary, Department of Health and Human Services
Most cited
By later US patents
- Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site1,449US 7,718,180 B22010
- Delivery of exogenous DNA sequences in a mammal1,218US 5,580,859 AVical Incorporated · 1996
- Induction of a protective immune response in a mammal by injecting a DNA sequence885US 5,589,466 AVical Incorporated · 1996
- Generation of antibodies through lipid mediated DNA delivery427US 5,703,055 AVical Incorporated · 1997
- Oligonucleotide mediated nucleic acid recombination400US 6,376,246 B1Maxygen, Inc. · 2002